OncoDNA is a company specialized in precision medicine for the treatment of cancer.
Oncodna has raised €19M across 1 funding round from 2 investors, most recently a Series B round in Feb 2020. Based in Gosselies, Belgium; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-14 | Series B | €19M |
| Swisscanto Private Equity,Vesalius Biocapital Partners |
| View deal → |
